• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者脑脊液中的神经系统特异性S-100抗原。

The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients.

作者信息

Michetti F, Massaro A, Murazio M

出版信息

Neurosci Lett. 1979 Feb;11(2):171-5. doi: 10.1016/0304-3940(79)90122-8.

DOI:10.1016/0304-3940(79)90122-8
PMID:460686
Abstract

The nervous system-specific S-100 antigen has been found in cerebrospinal fluid (CSF) of 13 out of 18 patients with multiple sclerosis (MS), whereas it was undetectable in either of the 11 control patients with minor psychic disturbances or with neurological disorders not usually associated with apparent parenchymal lesion. The levels of the antigen appeared to be higher in CSF of patients in the acute phase of the disease. Though the small number of cases hampers final statements, the S-100 in CSF might serve as a possible index of active cell injury in the central nervous system underlying the pathogenesis of MS.

摘要

在18例多发性硬化症(MS)患者中,有13例患者的脑脊液(CSF)中发现了神经系统特异性S-100抗原,而在11例患有轻度精神障碍或患有通常与明显实质病变无关的神经系统疾病的对照患者中,均未检测到该抗原。在疾病急性期患者的脑脊液中,该抗原水平似乎更高。尽管病例数量较少限制了最终结论,但脑脊液中的S-100可能作为MS发病机制中潜在的中枢神经系统活性细胞损伤的一个可能指标。

相似文献

1
The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients.多发性硬化症患者脑脊液中的神经系统特异性S-100抗原。
Neurosci Lett. 1979 Feb;11(2):171-5. doi: 10.1016/0304-3940(79)90122-8.
2
The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system.脑脊液中的S-100抗原作为神经系统细胞损伤的一种可能指标。
J Neurol Sci. 1980 Jan;44(2-3):259-63. doi: 10.1016/0022-510x(80)90133-1.
3
[IgM immunoglobulin in cerebrospinal fluid in cases of multiple sclerosis (preliminary report)].
Neurol Neurochir Pol. 1975 May-Jun;9(3):327-9.
4
T-lymphocyte subpopulation levels and immunoglobulin changes in the cerebrospinal fluid of patients with neurologic disorders.神经系统疾病患者脑脊液中T淋巴细胞亚群水平及免疫球蛋白变化
Ann N Y Acad Sci. 1987;496:691-6. doi: 10.1111/j.1749-6632.1987.tb35831.x.
5
Cerebrospinal fluid proteins in neurology.
Int Rev Neurobiol. 1984;25:95-138. doi: 10.1016/s0074-7742(08)60678-9.
6
Isoelectric focusing of cerebrospinal fluid proteins in the diagnosis of multiple sclerosis.脑脊液蛋白质等电聚焦在多发性硬化症诊断中的应用
Neurology. 1981 Jan;31(1):70-6. doi: 10.1212/wnl.31.1.70.
7
[Relation between the clinical and cerebrospinal fluid parameters in multiple sclerosis, with special reference to subjects without oligoclonal IgG in the cerebrospinal fluid].[多发性硬化症的临床与脑脊液参数之间的关系,特别提及脑脊液中无寡克隆IgG的受试者]
Riv Neurol. 1981 Mar-Apr;51(2):69-80.
8
The cerebrospinal fluid proteins in multiple sclerosis.
Clin Lab Med. 1986 Sep;6(3):457-75.
9
Immunoglobulin levels in the cerebrospinal fluid.脑脊液中的免疫球蛋白水平。
Br Med J. 1970 Feb 14;1(5693):396-9. doi: 10.1136/bmj.1.5693.396.
10
Myelin basic protein and S-100 antigen in cerebrospinal fluid of patients with multiple sclerosis in the acute phase.
Ital J Neurol Sci. 1985 Mar;6(1):53-6. doi: 10.1007/BF02229218.

引用本文的文献

1
The Multifaceted S100B Protein: A Role in Obesity and Diabetes?S100B 蛋白的多面性:在肥胖和糖尿病中的作用?
Int J Mol Sci. 2024 Jan 8;25(2):776. doi: 10.3390/ijms25020776.
2
The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker.S100B 蛋白:一种多效性的致病因子,不仅仅是一种生物标志物。
Int J Mol Sci. 2023 May 31;24(11):9605. doi: 10.3390/ijms24119605.
3
S100B inhibition protects from chronic experimental autoimmune encephalomyelitis.S100B抑制可预防慢性实验性自身免疫性脑脊髓炎。
Brain Commun. 2022 Mar 25;4(3):fcac076. doi: 10.1093/braincomms/fcac076. eCollection 2022.
4
S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis.S100B 蛋白作为多发性硬化症的治疗靶点:S100B 抑制剂阿仑珠单抗可预防慢性实验性自身免疫性脑脊髓炎。
Int J Mol Sci. 2021 Dec 17;22(24):13558. doi: 10.3390/ijms222413558.
5
The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing-Remitting Multiple Sclerosis Mouse Model.S100B 抑制剂戊二脒改善复发缓解型多发性硬化症小鼠模型的临床评分和神经病理学。
Cells. 2020 Mar 18;9(3):748. doi: 10.3390/cells9030748.
6
Integration of Biomarkers Into a Signature Profile of Persistent Traumatic Brain Injury Involving Autoimmune Processes Following Water Hammer Injury From Repetitive Head Impacts.生物标志物整合入持续性创伤性脑损伤的特征图谱,该损伤涉及重复性头部撞击所致水击伤后的自身免疫过程。
Biomark Insights. 2018 Oct 29;13:1177271918808216. doi: 10.1177/1177271918808216. eCollection 2018.
7
Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia.与血管性痴呆相比,阿尔茨海默病的脑脊液生物标志物呈现出不同但部分重叠的特征。
Front Aging Neurosci. 2017 Sep 12;9:289. doi: 10.3389/fnagi.2017.00289. eCollection 2017.
8
S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis.S100B作为多发性硬化症的潜在生物标志物和治疗靶点。
Mol Neurobiol. 2016 Aug;53(6):3976-3991. doi: 10.1007/s12035-015-9336-6. Epub 2015 Jul 17.
9
Functions of S100 proteins.S100 蛋白的功能。
Curr Mol Med. 2013 Jan;13(1):24-57.
10
Repeated intrathecal triamcinolone acetonide administration in progressive multiple sclerosis: a review.在进展性多发性硬化症中重复鞘内注射曲安奈德:一项综述
Mult Scler Int. 2011;2011:219049. doi: 10.1155/2011/219049. Epub 2011 Jun 26.